Jane Street Group, LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$20.94 - $27.5 $2.89 Million - $3.79 Million	-137,900 Reduced 63.84%	78,100 $1.89 Million
Q4 2021 Feb 15, 2022	BUY	$16.79 - $27.09 $3.02 Million - $4.87 Million	179,700 Added 495.04%	216,000 $5.04 Million
Q3 2021 Nov 16, 2021	SELL	$15.78 - $24.77 $1.38 Million - $2.16 Million	-87,400 Reduced 70.65%	36,300 $603,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $1.02 Million - $1.45 Million	52,700 Added 74.23%	123,700 $3.02 Million
Q1 2021 May 18, 2021	BUY	$25.02 - $54.99 $690,552 - $1.52 Million	27,600 Added 63.59%	71,000 $1.83 Million
Q4 2020 Feb 17, 2021	SELL	$41.04 - $56.79 $147,744 - $204,444	-3,600 Reduced 7.66%	43,400 $2.32 Million
Q3 2020 Nov 17, 2020	BUY	$36.42 - $57.0 $888,648 - $1.39 Million	24,400 Added 107.96%	47,000 $1.94 Million
Q2 2020 Aug 17, 2020	SELL	$39.26 - $52.73 $891,202 - $1.2 Million	-22,700 Reduced 50.11%	22,600 $1.1 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $981,150 - $1.45 Million	31,000 Added 216.78%	45,300 $1.91 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $282,438 - $400,920	-7,800 Reduced 35.29%	14,300 $612,000
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $35,552 - $70,416	1,600 Added 7.8%	22,100 $795,000
Q2 2019 Aug 15, 2019	SELL	$23.32 - $28.12 $186,560 - $224,960	-8,000 Reduced 28.07%	20,500 $548,000
Q1 2019 May 16, 2019	BUY	$16.17 - $27.38 $177,870 - $301,180	11,000 Added 62.86%	28,500 $765,000
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $164,178 - $274,806	-12,600 Reduced 41.86%	17,500 $363,000
Q2 2018 Aug 15, 2018	BUY	$15.07 - $22.34 $280,302 - $415,524	18,600 Added 161.74%	30,100 $460,000
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $49,434 - $71,126	-2,200 Reduced 16.06%	11,500 $258,000
Q4 2017 Feb 15, 2018	BUY	$26.84 - $39.14 $367,708 - $536,218	13,700	13,700 $413,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account